EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 22 / No 8-9 (Août–Septembre 2006) Med Sci (Paris), 22 8-9 (2006) 745-750 References
Free Access
Issue
Med Sci (Paris)
Volume 22, Number 8-9, Août–Septembre 2006
Page(s) 745 - 750
Section M/S revues
DOI https://doi.org/10.1051/medsci/20062289745
Published online 15 August 2006
  1. Caucheteux SM, Kanellopoulos-Langevin C, Ojcius DM. At the innate frontiers between mother and fetus : linking abortion with complement activation. Immunity 2003; 18 : 169–72. [Google Scholar]
  2. Chaouat G, Ledee-Bataille N, Dubanchet S,et al. Reproductive immunology 2003 : reassessing the Th1/Th2 paradigm ? Immunol Lett 2004; 92 : 207–14. [Google Scholar]
  3. Ledee-Bataille N. Materno-foetal dialogue and human embryo implantation : some evolving concepts. J Gynecol Obstet Biol Reprod 2004; 33 : 564–76. [Google Scholar]
  4. Moffett A, Loke YW. The immunological paradox of pregnancy : a reappraisal. Placenta 2004; 25 : 1–8. [Google Scholar]
  5. Hunt J, Petroff M, McIntire R,et al. HLA-G and immune tolerance in pregnancy. FASEB J 2005; 19 : 681–93. [Google Scholar]
  6. Le Bouteiller P, Pröll J. Immunologie placentaire : le fœtus face à un double défi. Réalités en Gynécologie-Obstétrique 2001; 57 : 9–17. [Google Scholar]
  7. Morales P, Pace J, Platt J,et al. Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype. J Immunol 2003; 171 : 6215–24. [Google Scholar]
  8. Solier C, Aguerre-Girr M, Lenfant F,et al. Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast. Eur J Immunol 2002; 32 : 3576–86. [Google Scholar]
  9. Holmes C, Simpson K, Okada H,et al. Complement regulatory proteins at the feto-maternal interface during human placental development : distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55). Eur J Immunol 1992; 22 : 1579–85. [Google Scholar]
  10. Xu C, Mao D, Holers VM,et al. A critical role for murine complement regulator crry in fetomaternal tolerance. Science 2000; 287 : 498–501. [Google Scholar]
  11. Girardi G, Bulla R, Salmon JE,et al. The complement system in the pathophysiology of pregnancy. Mol Immunol 2006; 43 : 68–77. [Google Scholar]
  12. Aït-Azzouzene D, Gendron M, Houdayer M,et al. Maternal B lymphocytes specific for paternal histocompatibility antigens are partially deleted during pregnancy. J Immunol 1998; 161 : 2677–83. [Google Scholar]
  13. Contini P, Ghio M, Poggi A,et al. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 2003; 33 : 125–34. [Google Scholar]
  14. Pröll J, Bensussan A, Goffin F,et al. Tubal versus uterine placentation : similar HLA-G expressing extravillous cytotrophoblast invasion but different maternal leukocyte recruitment. Tissue Antigens 2000; 56 : 479–91. [Google Scholar]
  15. Slager HG, Van Inzen W, Freund E,et al. Transforming growth factor-beta in the early mouse embryo : implications for the regulation of muscle formation and implantation. Dev Genet 1993; 14 : 212–24. [Google Scholar]
  16. Szekeres-Bartho J, Barakonyi A, Par G,et al. Progesterone as an immunomodulatory molecule. Int Immunopharmacol 2001; 1 : 1037–48. [Google Scholar]
  17. Mellor AL, Munn DH. Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses. J Reprod Immunol 2001; 52 : 5–13. [Google Scholar]
  18. Hunt JS, Vassmer D, Ferguson TA,et al. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J Immunol 1997; 158 : 4122–8. [Google Scholar]
  19. Fournel S, Aguerre-Girr M, Huc X,et al. Cutting Edge : Soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 2000; 164 : 6100–4. [Google Scholar]
  20. Tafuri A, Alferink J, Moller P,et al. T cell awareness of paternal allo-antigens during pregnancy. Science 1995; 270 : 630–3. [Google Scholar]
  21. Jiang S, Vacchio M. Multiple mechanisms of peripheral T cell tolerance to the fetal allograft. J Immunol 1998; 160 : 3086–90. [Google Scholar]
  22. Loke YW, King A, Burrows TD. Decidua in human implantation. Hum Reprod 1995; 10 Suppl 2 : 14–21. [Google Scholar]
  23. Tabiasco J, Rabot M, Aguerre-Girr M,et al. Human decidual NK cells : unique phenotype and functional properties: a review. Placenta 2006; 27(suppl 1) : 34–9. [Google Scholar]
  24. Le Bouteiller P, Barakonyi A, Giustiniani J,et al. Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc Natl Acad Sci USA 2002; 99 : 16963–8. [Google Scholar]
  25. Rabot M, Tabiasco J, Polgar B,et al. HLA Class I/NK cell receptor interaction in early human decidua basalis : possible functional consequences. Chem Immunol Allergy 2005; 89 : 72–83. [Google Scholar]
  26. Koopman L, Kopcow H, Rybalov B,et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential J Exp Med 2003; 198 : 1201–12. [Google Scholar]
  27. Kopcow HD, Allan DS, Chen X,et al. Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc Natl Acad Sci USA 2005; 102 : 15563–8. [Google Scholar]
  28. Avril T, Jarousseau AC, Watier H,et al. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.J Immunol 1999; 162 : 5902–9. [Google Scholar]
  29. Chumbley G, King A, Robertson K,et al. Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells. Cell Immunol1994; 155 : 312–22. [Google Scholar]
  30. Straszewski-Chavez S, Abrahams V, Funai E,et al. X-linked inhibitor of apoptosis (XIAP) confers human trophoblast cell resistance to Fas-mediated apoptosis. Mol Hum Reprod 2004; 10 : 33–41. [Google Scholar]
  31. Hiby SE, Walker JJ, O’Shaughnessy K M,et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004; 200 : 957–65. [Google Scholar]
  32. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308 : 1592–4. [Google Scholar]
  33. Rajagopalan S, Bryceson YT, Kuppusamy SP,et al. Activation of NK Cells by an endocytosed receptor for soluble HLA-G. PLoS Biol 2006; 4 : e9. [Google Scholar]
  34. Croy BA, He H, Esadeg S, et al. Uterine natural killer cells : insights into their cellular and molecular biology from mouse modelling. Reproduction 2003; 126 : 149–60. [Google Scholar]
  35. Guimond MJ, Wang B, Croy BA. Engraftment of bone marrow from severe combined immunodeficient (SCID) mice reverses the reproductive deficits in natural killer cell-deficient tg epsilon 26 mice. J Exp Med 1998; 187 : 217–23. [Google Scholar]
  36. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5 : 266–71. [Google Scholar]
  37. Sasaki Y, Sakai M, Miyazaki S,et al. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 2004; 10 : 347–53. [Google Scholar]
  38. Fallarino F, Grohmann U, Hwang KW,et al. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 2003; 4 : 1206–12. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.